Innovation & intellectual property · 26/05/2017Updated: 10/17/2026 · 1 min read
LOCILEX Receives Interim Patent Extension for Pexiganan
Summary
The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 5,912,231, which is held by LOCILEX, for its medication pexiganan.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →